NEURODERM LTD's ticker is and the CUSIP is M74231107. A total of 74 filers reported holding NEURODERM LTD in Q2 2017. The put-call ratio across all filers is 0.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $68,000 | +112.5% | 2,590 | +75.0% | 0.01% | +75.0% |
| Q4 2016 | $32,000 | -3.0% | 1,480 | -17.2% | 0.00% | 0.0% |
| Q3 2016 | $33,000 | +50.0% | 1,788 | +33.3% | 0.00% | +33.3% |
| Q2 2016 | $22,000 | +29.4% | 1,341 | +9.0% | 0.00% | +50.0% |
| Q1 2016 | $17,000 | +21.4% | 1,230 | +50.0% | 0.00% | +100.0% |
| Q4 2015 | $14,000 | – | 820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 261,945 | $4,466,000 | 3.96% |
| ACUTA CAPITAL PARTNERS, LLC | 477,300 | $8,138,000 | 3.89% |
| Avoro Capital Advisors LLC | 520,022 | $8,866,000 | 3.05% |
| Redmile Group, LLC | 1,589,261 | $27,097,000 | 2.03% |
| NEXTHERA CAPITAL LP | 48,000 | $818,000 | 1.16% |
| SCOPIA CAPITAL MANAGEMENT LP | 2,749,038 | $46,871,000 | 0.93% |
| SENZAR ASSET MANAGEMENT, LLC | 201,700 | $3,438,985,000 | 0.38% |
| Perceptive Advisors | 270,000 | $4,604,000 | 0.34% |
| Foresite Capital Management II, LLC | 55,779 | $951,000 | 0.32% |
| RA Capital Management | 144,671 | $2,467,000 | 0.24% |